SYNERGYST II PULSE GENERATOR MODELS 7070 & 7071
Medtronic, Inc. · Decision date Oct 30, 2025
What did the FDA approve?
FDA records P890003/S481 as a supplement to PMA P890003, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Oct 30, 2025.
FDA approval order statement
Approval for updated labeling to include results from the post approval study (PAS) Heart Failure Risk Status (HFRS) PAS, as summarized in the final report P890003/R098.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 30, 2025
- FDA change category
- Labeling Change - PAS
Regulatory record facts
- Identifier
- P890003/S481
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NVZ
- Decision code
- APPR
- Decision date
- Oct 30, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulse generator, permanent, implantable.
- Applicant
- Medtronic, Inc.
- Product code
- NVZ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P890003/S481 received
Application receipt date recorded by FDA.
P890003/S482 · Related supplement
CareLink SmartSync Device Manager Base
P890003/S481 · FDA decision
Normal 180 Day Track No User Fee
P890003/S483 · Related supplement
CareLink SmartSync Device Manager Base 24970A
P890003/S484 · Related supplement
CapSure VDD-2 Lead 5038, 5038L, 5038S Service Kit-Pacemaker Repair Kit 5873C Vitatron Brilliant S+ VDD Lead IMW14Q, IMW1
P890003/S486 · Related supplement
CapSure VDD-2 Lead (5038L, 5038S), CapSure VDD-2 Lead (5038), Service Kit-Pacemaker Repair Kit (5873C)
P890003/S485 · Related supplement
CareLink SmartSync Platform Application (M01A01); CareLink SmartSync Common Application (M01A02); CareLink SmartSync Hos
P890003/S487 · Related supplement
CareLink SmartSync Device Manager Base (24970A)
Timeline entries are records held by MedtechLedger for P890003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P890003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CareLink SmartSync Device Manager BaseP890003/S482 | Medtronic, Inc. | PMA supplement | Aug 12, 2025 | FDA |
CareLink SmartSync Device Manager Base 24970AP890003/S483 | Medtronic, Inc. | PMA supplement | Dec 3, 2025 | FDA |
| Medtronic, Inc. | PMA supplement | Feb 10, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Apr 15, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | May 6, 2026 | FDA | |
CareLink SmartSync Device Manager Base (24970A)P890003/S487 | Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA |
Explore the linked device profile
Other records with product code NVZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 5, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P890003/S481
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





